skip to primary navigationskip to content

Recent publication in collaboration with Dr Peter Scott’s group in The University of Michigan Medical School.

last modified May 20, 2015 03:45 PM
Synthesis and Initial in Vivo Studies with [11C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3

WBIC PET Chemistry team has a recent publication in collaboration with Dr Peter Scott’s group in The University of Michigan Medical School.

We have developed a novel one-pot two-step method for the radiosynthesis of [11C]SB-216763 and demonstrated that it is the first radiotracer for GSK-3 able to cross the Blood-brain Barrier and enter the central nervous system in both rodents and nonhuman primates. The arylindolemaleimide skeleton represents our lead scaffold for developing a radiotracer for quantification of GSK-3 in vivo using brain PET and ultimately translating it into clinical use.

 

The article is published in recent journal of ACS Medicinal Chemistry Letters

 

http://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.5b00044

WBIC Applications

Please click on the following buttons to view information on how to apply for scanning at the WBIC:

wbic_roadmap

wbic_information

wbic_application

To find the next submission deadline for WBIC applications, please refer to the 'upcoming events' section below.

Upcoming events

WBIC Safety Course

Dec 02, 2019

Large Seminar Room at the West Forvie Building

Previous events

Upcoming events